Sand Hill Global Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,731
| Closed | -$303K | – | 202 |
|
|
2025
Q3 | $303K | Hold |
2,731
| – | – | 0.01% | 166 |
|
|
2025
Q2 | $303K | Buy |
+2,731
| New | +$291K | 0.01% | 171 |
|
|
2021
Q4 | – | Sell |
-32,785
| Closed | -$2.29M | – | 159 |
|
|
2021
Q3 | $2.29M | Sell |
32,785
-468
| -1% | -$32.9K | 0.14% | 74 |
|
|
2021
Q2 | $2.29M | Buy |
33,253
+1,585
| +5% | +$106K | 0.14% | 72 |
|
|
2021
Q1 | $2.05M | Buy |
31,668
+2,199
| +7% | +$142K | 0.13% | 72 |
|
|
2020
Q4 | $1.72M | Sell |
29,469
-11,673
| -28% | -$704K | 0.11% | 74 |
|
|
2020
Q3 | $2.6M | Sell |
41,142
-1,320
| -3% | -$91.5K | 0.2% | 59 |
|
|
2020
Q2 | $3.27M | Sell |
42,462
-3,360
| -7% | -$258K | 0.26% | 55 |
|
|
2020
Q1 | $3.43M | Buy |
45,822
+292
| +0.6% | +$20.2K | 0.33% | 45 |
|
|
2019
Q4 | $2.96M | Sell |
45,530
-593,465
| -93% | -$38.6M | 0.27% | 63 |
|
|
2019
Q3 | $40.5M | Buy |
638,995
+590,739
| +1,224% | +$38.6M | 3.8% | 7 |
|
|
2019
Q2 | $3.26M | Sell |
48,256
-821
| -2% | -$54K | 0.33% | 54 |
|
|
2019
Q1 | $3.19M | Sell |
49,077
-1,696
| -3% | -$113K | 0.33% | 55 |
|
|
2018
Q4 | $3.18M | Sell |
50,773
-16,545
| -25% | -$1.16M | 0.34% | 56 |
|
|
2018
Q3 | $5.2M | Sell |
67,318
-5,012
| -7% | -$379K | 0.5% | 36 |
|
|
2018
Q2 | $5.12M | Buy |
72,330
+65,933
| +1,031% | +$4.66M | 0.51% | 35 |
|
|
2018
Q1 | $482K | Sell |
6,397
-69,577
| -92% | -$5.53M | 0.47% | 46 |
|
|
2017
Q4 | $5.44M | Sell |
75,974
-183
| -0.2% | -$13.9K | 0.54% | 35 |
|
|
2017
Q3 | $6.17M | Sell |
76,157
-960
| -1% | -$73.4K | 0.66% | 25 |
|
|
2017
Q2 | $5.46M | Sell |
77,117
-1,033
| -1% | -$68.7K | 0.62% | 31 |
|
|
2017
Q1 | $5.31M | Buy |
78,150
+1,471
| +2% | +$103K | 0.69% | 26 |
|
|
2016
Q4 | $5.49M | Buy |
76,679
+25,055
| +49% | +$1.86M | 0.75% | 25 |
|
|
2016
Q3 | $4.08M | Buy |
51,624
+304
| +0.6% | +$24.7K | 0.62% | 36 |
|
|
2016
Q2 | $4.28M | Buy |
51,320
+2,177
| +4% | +$193K | 0.67% | 31 |
|
|
2016
Q1 | $4.51M | Buy |
49,143
+1,302
| +3% | +$117K | 0.69% | 29 |
|
|
2015
Q4 | $4.84M | Sell |
47,841
-950
| -2% | -$98.9K | 0.78% | 22 |
|
|
2015
Q3 | $4.79M | Sell |
48,791
-5,071
| -9% | -$563K | 0.77% | 24 |
|
|
2015
Q2 | $6.31M | Buy |
53,862
+6,881
| +15% | +$752K | 1.03% | 17 |
|
|
2015
Q1 | $4.61M | Buy |
46,981
+7,552
| +19% | +$767K | 0.75% | 24 |
|
|
2014
Q4 | $3.72M | Sell |
39,429
-1,855
| -4% | -$192K | 0.64% | 39 |
|
|
2014
Q3 | $4.39M | Buy |
41,284
+2,659
| +7% | +$260K | 0.73% | 27 |
|
|
2014
Q2 | $3.2M | Buy |
+38,625
| New | +$3.01M | 0.6% | 41 |
|
Other funds holding GILD
Sand Hill Global Advisors's GILD Position: Q4 2025 in Review
Sand Hill Global Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,731 shares — an estimated $303K sold.
Sand Hill Global Advisors first reported a position in GILD in Q2 2014 and held it in 32 quarters. The position peaked at $40.5M in Q3 2019. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Sand Hill Global Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Sand Hill Global Advisors sold 2,731 Gilead Sciences shares in Q4 2025, an estimated $303K.
- Sand Hill Global Advisors first reported a position in Gilead Sciences in Q2 2014 and held it in 32 quarters.
- Sand Hill Global Advisors's Gilead Sciences position peaked at $40.5M in Q3 2019.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Sand Hill Global Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.